Skip to main content

Advertisement

SpringerLink
Log in

Cytokine and anti-cytokine therapy for asthma

  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

Cytokines play a critical role in the pathogenesis of asthma. Asthma resolution may depend on the correction of dysregulated cytokine expression, which is a characteristic feature of this chronic inflammatory disease. It is, therefore, not surprising that attempts have been made to either block cytokines present at elevated levels or to substitute cytokines that are insufficiently expressed in asthma. In this article, the results of these studies are discussed, and the obtained insights regarding asthma pathogenesis and new treatment options are summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Tattersfield AE, Knox AJ, Britton JR, Hall IP: Asthma. Lancet 2002, 360:1313–1322.

    Article  PubMed  CAS  Google Scholar 

  2. Busse WW, Rosenwasser LJ: Mechanisms of asthma. J Allergy Clin Immunol 2003, 111:S799-S804.

    Article  PubMed  CAS  Google Scholar 

  3. Romagnani S: Immunologic influences on allergy and TH1/TH2 balance. J Allergy Clin Immunol 2004, 113:395–400.

    Article  PubMed  CAS  Google Scholar 

  4. Gavett SH, O’Hearn DJ, Karp CL, et al.: Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol 1997, 272:L253-L261.

    PubMed  CAS  Google Scholar 

  5. Borish LC, Nelson HS, Lanz MJ, et al.: Interleukin-4 receptor in moderate atopic asthma: a phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999, 160:1816–1823.

    PubMed  CAS  Google Scholar 

  6. Economides AN, Carpenter LR, Rudge JS, et al.: Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat Med 2003, 9:47–52.

    Article  PubMed  CAS  Google Scholar 

  7. Shanafelt AB, Forte CP, Kasper JJ, et al.: An immune cellselective interleukin-4 agonist. Proc Natl Acad Sci U S A 1998, 95:9454–9458.

    Article  PubMed  CAS  Google Scholar 

  8. Wills-Karp M, Luyimbazi J, Xu X, et al.: Interleukin-13: central mediator of allergic asthma. Science 1998, 282:2258–2261. The results of this study suggest that IL-13 is an important drug target in asthma.

    Article  PubMed  CAS  Google Scholar 

  9. Simon HU: Eosinophil apoptosis-pathophysiologic and therapeutic implications. Allergy 2000, 55:910–915.

    Article  PubMed  CAS  Google Scholar 

  10. Hamelmann E, Gelfand EW: IL-5-induced airway eosinophilia: the key to asthma? Immunol Rev 2001, 179:182–191.

    Article  PubMed  CAS  Google Scholar 

  11. Leckie MJ, ten Brinke A, Khan J, et al.: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000, 356:2144–2148.

    Article  PubMed  CAS  Google Scholar 

  12. Kips JC, O’Connor BJ, Langley SJ, et al.: Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. Am J Respir Crit Care Med 2003, 167:1655–1659.

    Article  PubMed  Google Scholar 

  13. Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS: Eosinophil’s role remains uncertain as anti-IL-5 only partially depletes numbers in asthmatic airways. Am J Respir Crit Care Med 2003, 167:199–204.

    Article  PubMed  Google Scholar 

  14. Simon HU, Youse S, Schranz C, et al.: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997, 158:3902–3908.

    PubMed  CAS  Google Scholar 

  15. Plötz SG, Simon HU, Darsow U, et al.: Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 2003, 349:2332–2337. The first study demonstrating the clinical efficacy of a blocking antibody to IL-5 in a subgroup of the hypereosinophilic syndrome.

    Article  Google Scholar 

  16. Morokata T, Ida K, Yamada T: Characterization of YM-90709 as a novel antagonist which inhibits the binding of interleukin-5 to interleukin-5 receptor. Int Immunopharmacol 2002, 2:1693–1702.

    Article  PubMed  CAS  Google Scholar 

  17. Trinchieri G, Pflanz S, Kastelein RA: The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003, 19:641–644.

    Article  PubMed  CAS  Google Scholar 

  18. van der Pouw Kraan TC, Boeije LC, de Groot ER, et al.: Reduced production of IL-12 and IL-12-dependent IFNgamma release in patients with allergic asthma. J Immunol 1997, 158:5560–5565.

    PubMed  Google Scholar 

  19. Bryan S, O’Connor BJ, Matti S, et al.: Effects of recombinant human interleukin-12 on eosinophils, airway hyperreactivity, and the late asthmatic response. Lancet 2000, 356:2149–2153.

    Article  PubMed  CAS  Google Scholar 

  20. Smart JM, Horak E, Kemp AS, et al.: Polyclonal and allergen-induced cytokine responses in adults with asthma: resolution of asthma is associated with normalization of interferon-gamma responses. J Allergy Clin Immunol 2002, 110:450–456.

    Article  PubMed  CAS  Google Scholar 

  21. Simon D, Borelli S, Braathen LR, Simon HU: Peripheral blood mononuclear cells from IgE- and non-IgE-associated allergic atopic eczema/dermatitis syndrome (AEDS) demonstrate increased capacity of generating interleukin-13 but differ in their potential of synthesizing interferon-gamma. Allergy 2002, 57:431–435.

    Article  PubMed  CAS  Google Scholar 

  22. Till SJ, Francis JN, Nouri-Aria K, Durham SR: Mechanisms of immunotherapy. J Allergy Clin Immunol 2004, 113:1025–1034.

    Article  PubMed  CAS  Google Scholar 

  23. Boguniewicz M, Martin RJ, Martin D, et al.: The effects of nebulized recombinant interferon-g in asthmatic airways. J Allergy Clin Immunol 1995, 95:133–135.

    Article  PubMed  CAS  Google Scholar 

  24. Rogge L, D’Ambrosio D, Bif M, et al.: The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol 1998, 161:6567–6574.

    PubMed  CAS  Google Scholar 

  25. Simon HU, Seelbach H, Ehmann R, Schmitz M: Clinical and immunological effects of low-dose IFN-a treatment in patients with corticosteroid-resistant asthma. Allergy 2003, 58:1250–1255. A study of IFN-α therapy in severe asthma, with recommendations for immune monitoring.

    Article  PubMed  CAS  Google Scholar 

  26. Gratzl S, Palca A, Schmitz M, Simon HU: Treatment with IFN-alpha in corticosteroid-unresponsive asthma. J Allergy Clin Immunol 2000, 105:1035–1036.

    Article  PubMed  CAS  Google Scholar 

  27. Kroegel C, Bergmann N, Foerster M, et al.: Interferonalphacon-1 treatment of three patients with severe glucocorticoid-dependent asthma. Respiration 2005, Epub ahead of print

  28. Kanazawa H, Mamoto T, Hirata K, Yoshikawa J: Interferon therapy induces the improvement of lung function by inhaled corticosteroid therapy in asthmatic patients with chronic hepatitis C virus infection: a preliminary study. Chest 2003, 123:600–603.

    Article  PubMed  CAS  Google Scholar 

  29. Broide DH, Campbell K, Gifford T, Sriramarao P: Inhibition of eosinophilic inflammation in allergenchallenged, IL-1 receptor type 1-deficient mice is associated with reduced eosinophil rolling and adhesion on vascular endothelium. Blood 2000, 95:263–269.

    PubMed  CAS  Google Scholar 

  30. Thomas PS: Tumour necrosis factor a: the role of this multifunctional cytokine in asthma. Immunol Cell Biol 2001, 79:132–140.

    Article  PubMed  CAS  Google Scholar 

  31. Vassina E, Leverkus M, Youse S, et al.: Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis. J Invest Dermatol 2005, 125:746–752.

    Article  PubMed  CAS  Google Scholar 

  32. Straumann A, Bauer M, Fischer B, et al.: Idiopathic eosinophilic esophagitis is associated with a Th2-type allergic inflammatory response. J Allergy Clin Immunol 2001, 108:954–961.

    Article  PubMed  CAS  Google Scholar 

  33. Bihl T, Vassina E, Boettger MK, et al.: The T348M mutated form of cryopyrin is associated with defective lipopolysaccharide-induced interleukin 10 production in CINCA syndrome. Ann Rheum Dis 2005, 64:1380–1381.

    Article  PubMed  CAS  Google Scholar 

  34. Seitz M, Kamgang RK, Simon HU, Villiger PM: Therapeutic interleukin (IL) 1 blockade normalises increased IL1β and decreased tumour necrosis factor α and IL10 production in blood mononuclear cells of a patient with CINCA syndrome. Ann Rheum Dis 2005, 64:1802–1803.

    Article  PubMed  CAS  Google Scholar 

  35. Rosenwasser LJ: Biological activities of IL-1 and its role in human disease. J Allergy Clin Immunol 1998, 102:344–350.

    Article  PubMed  CAS  Google Scholar 

  36. Ohkawara Y, Yamauchi K, Tanno Y, et al.: Human lung mast cells and pulmonary macrophages produce tumor necrosis factor-alpha in sensitized lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol 1992, 7:385–392.

    PubMed  CAS  Google Scholar 

  37. Finotto S, Ohno I, Marshall JS, et al.: TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis). J Immunol 1994, 153:2278–2289.

    PubMed  CAS  Google Scholar 

  38. Bodey KJ, Semper AE, Redington AE, et al.: Cytokine profiles of BAL T-cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy 1999, 54:1083–1093.

    Article  PubMed  CAS  Google Scholar 

  39. Abdelaziz MM, Devalia JL, Khair OA, et al.: The effect of conditioned medium from cultured human bronchial epithelial cells on eosinophil and neutrophil chemotaxis and adherence in vitro. Am J Respir Cell Mol Biol 1995, 13:728–737.

    PubMed  CAS  Google Scholar 

  40. Pennings HJ, Kramer K, Bast A, et al.: TNF-alpha induces hyperreactivity in tracheal smooth muscle of the guineapig in vitro. Eur Respir J 1998, 12:45–49.

    Article  PubMed  CAS  Google Scholar 

  41. Thomas PS, Yates DH, Barnes PJ: Tumor necrosis factor alpha increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995, 152:76–80.

    PubMed  CAS  Google Scholar 

  42. Renzetti LM, Paciorek PM, Tannu SA, et al.: Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways. J Pharmacol Exp Ther 1996, 278:847–853.

    PubMed  CAS  Google Scholar 

  43. Khalil-Saadeh C, Brown DM, Chumney-Malacara J, Crow J: Infliximab therapy for rheumatoid arthritis (RA) induced significant control of asthma in patients with both RA and asthma or asthma/COPD in addition to mproving RA status. J Allergy Clin Immunol 2002, 109(Suppl 1):s243.

    Article  Google Scholar 

  44. Howarth PH, Babu KS, Arshad HS, et al.: Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid-dependent asthma. Thorax 2005, 60:1012–1018. This study demonstrates that anti-TNF-alpha therapy is useful in severe asthma.

    Article  PubMed  CAS  Google Scholar 

  45. Rouhani FN, Meitin CA, Kaler M, et al.: Effect of tumor necrosis factor antagonism on allergen-mediated asthmatic airway inflammation. Respir Med 2005, 99:1175–1182.

    Article  PubMed  Google Scholar 

  46. Keane J, Gershon S, Wise RP, et al.: Tuberculosis associated with infliximab, a TNF-alpha neutralizing agent. N Engl J Med 2001, 345:1098–1104.

    Article  PubMed  CAS  Google Scholar 

  47. Mohan N, Edwards ET, Cupps TR, et al.: Demyelination occuring during anti-tumor necrosis factor-alpha therapy for inflammatory arthritides. Arthritis Rheum 2001, 44:2862–2869.

    Article  PubMed  CAS  Google Scholar 

  48. Akdis M, Blaser K, Akdis CA: T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005, 116:961–968.

    Article  PubMed  CAS  Google Scholar 

  49. Barnes PJ: IL-10: a key regulator of allergic disease. Clin Exp Allergy 2001, 31:667–669.

    Article  PubMed  CAS  Google Scholar 

  50. Borish L, Aarons A, Rumbyrt J, et al.: Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996, 97:1288–1296.

    Article  PubMed  CAS  Google Scholar 

  51. Zuany-Amorim C, Haile S, Leduc D, et al.: Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest 1995, 95:2644–2651.

    Article  PubMed  CAS  Google Scholar 

  52. Fedorak RN, Gangl A, Elson CO, et al.: Recombinant human interleukin 10 in the treatment of patients with mild to moderate active Crohn’s disease. Gastroenterology 2000, 119:1473–1482.

    Article  PubMed  CAS  Google Scholar 

  53. McMillan SJ, Xanthou G, Lloyd CM: Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-β antibody: effect on the Smad signaling pathway. J Immunol 2005, 174:5774–5780.

    PubMed  CAS  Google Scholar 

  54. Cheng G, Arima M, Honda K, et al.: Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med 2002, 166:409–416.

    Article  PubMed  Google Scholar 

  55. Rückert R, Brandt K, Braun A, et al.: Blocking IL-15 prevents the induction of allergen-specific T cells and allergic inflammation in vivo. J Immunol 2005, 174:5507–5515.

    PubMed  Google Scholar 

  56. Barnes PJ: New drugs for asthma. Nat Rev 2004, 3:831–844. A comprehensive review of current drug developments for asthma.

    CAS  Google Scholar 

  57. Proudfoot AE: Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2002, 2:106–115.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of Bern, Friedbühlstrasse 49, CH-3010, Bern, Switzerland

    Hans-Uwe Simon MD, PhD

Authors
  1. Hans-Uwe Simon MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Uwe Simon MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simon, HU. Cytokine and anti-cytokine therapy for asthma. Curr Allergy Asthma Rep 6, 117–121 (2006). https://doi.org/10.1007/s11882-006-0049-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-006-0049-9

Keywords

Search

Navigation